Factors affecting success of thymus transplantation for complete DiGeorge anomaly

American Journal of Transplantation

Volumn 8, Issue 8, 2008, Pages 1729-1736

  Markert, M L ^a   Devlin, B H ^a   Chinn, I K ^a   McCarthy, E A ^a   Li, Y J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Thymus; Transplantation

Indexed keywords

ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CELL MATURATION; CLINICAL ARTICLE; CULTURE MEDIUM; DIGEORGE SYNDROME; DOSE RESPONSE; HLA MATCHING; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; ORGAN DONOR; ORGAN SIZE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; THYMUS GRAFT; THYMUS TRANSPLANTATION; TREATMENT OUTCOME;

ABO BLOOD-GROUP SYSTEM; DIGEORGE SYNDROME; FEMALE; HLA ANTIGENS; HUMANS; INFANT; INFANT, NEWBORN; MALE; THYMUS GLAND; TREATMENT OUTCOME;

EID: 48349132851     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02301.x     Document Type: Article

References (24)

1. Sullivan KE, Jawad AF, Randall P et al. Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes. Clin Immunol Immunopathol 1998 86 : 141 146.
2. Conley ME, Beckwith JB, Mancer JF, Tenckhoff L. The spectrum of the DiGeorge syndrome. J Pediatr 1979 94 : 883 890.
3. Hong R. The DiGeorge anomaly. Clin Rev Allergy Immunol 2001 20 : 43 60.
4. Barrett DJ, Ammann AJ, Wara DW, Cowan MJ, Fisher TJ, Stiehm ER. Clinical and immunologic spectrum of the DiGeorge syndrome. J Clin Lab Immunol 1981 6 : 1 6.
5. Thomas RA, Landing BH, Wells TR. Embryologic and other developmental considerations of thirty-eight possible variants of the DiGeorge anomaly. Am J Med Genet Suppl 1987 3 : 43 66.
6. Muller W, Peter HH, Wilken M et al. The DiGeorge syndrome. I. Clinical evaluation and course of partial and complete forms of the syndrome. Eur J Pediatr 1988 147 : 496 502.
7. Bastian J, Law S, Vogler L et al. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr 1989 115 : 391 396.
8. Markert ML, Hummell DS, Rosenblatt HM et al. Complete DiGeorge syndrome: Persistence of profound immunodeficiency. J Pediatr 1998 132 : 15 21.
9. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Buck D, Terstappen LW. Control of lymphocyte recirculation in man. I. Differential regulation of the peripheral lymph node homing receptor L-selection on T cells during the virgin to memory cell transition. J Immunol 1993 150 : 1105 1121.
10. Markert ML, Devlin BH, Alexieff MJ et al. Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: Outcome of 44 consecutive transplants. Blood 2007 109 : 4539 4547.
11. Markert ML, Alexieff MJ, Li J et al. Complete DiGeorge syndrome: Development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol 2004 113 : 734 741.
12. Selim MA BJ, Herman CM, Turner JW, Markert ML. The cutaneous manifestations of atypical complete DiGeorge syndrome: A histopathologic and immunohistochemical study. J Cutan Pathol 2008 35 : 380 385.
13. Markert ML, Alexieff MJ, Li J et al. Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood 2004 104 : 2574 2581.
14. 2006. Title 21-Food and Drugs; Chapter I-Food and Drug Administration, Department of Health and Human; Subchapter L-Regulations Under Certain Other Acts Administered by the Food and Drug Administration, Part 1270 Human Tissue Intended for Transplantation, Code of Federal Regulations.
15. Hong R, Moore AL. Organ culture for thymus transplantation. Transplantation 1996 61 : 444 448.
16. Kepler TB, He M, Tomfohr JK, Devlin BH, Sarzotti M, Markert ML. Statistical analysis of antigen receptor spectratype data. Bioinformat 2005 21 : 3394 3400.
17. Choi EY, Jung KC, Park HJ et al. Thymocyte-thymocyte interaction for efficient positive selection and maturation of CD4 T cells. Immunity 2005 23 : 387 396.
18. Li W, Kim MG, Gourley TS, McCarthy BP, Sant'Angelo DB, Chang CH. An alternate pathway for CD4 T cell development: Thymocyte-expressed MHC class II selects a distinct T cell population. Immunity 2005 23 : 375 386.
19. Bix M, Raulet D. Inefficient positive selection of T cells directed by haematopoietic cells. Nature 1992 359 : 330 333.
20. Hugo P, Kappler JW, McCormack JE, Marrack P. Fibroblasts can induce thymocyte positive selection in vivo. Proc Natl Acad Sci USA 1993 90 : 10335 10339.
21. Martinic MM, Rulicke T, Althage A et al. Efficient T cell repertoire selection in tetraparental chimeric mice independent of thymic epithelial MHC. Proc Natl Acad Sci USA 2003 100 : 1861 1866.
22. Pawlowski T, Elliott JD, Loh DY, Staerz UD. Positive selection of T lymphocytes on fibroblasts. Nature 1993 364 : 642 645.
23. Markert ML, Devlin BH. Thymic reconstitution. In : Rich RR, Shearer WT, Fleischer T, Schroeder HW, Weyand CM, Frew A, eds. Clinical Immunology, 3rd Ed. Edinburgh : Elsevier : 1253 1262, 2008.
24. Markert ML, Li J, Devlin BH et al. Use of allograft biopsies to assess thymopoiesis after thymus transplantation. J Immunol 2008 180 : 6354 6364.